VOYA Investment Management
SPRO icon

VOYA Investment Management’s Spero Therapeutics SPRO Stock Holding History

VOYA Investment Management’s Portfolio SPRO Stock Details SPRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,124
Closed -$186K – 2818
2021
Q3 		$186K Hold
10,124
– – ﹤0.01% 2597
2021
Q2 		$141K Buy
+10,124
New +$141K ﹤0.01% 2691
2020
Q4 		– Sell
-14,646
Closed -$163K – 2693
2020
Q3 		$163K Buy
+14,646
New +$173K ﹤0.01% 2220

Other funds holding SPRO

ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

VOYA Investment Management's SPRO Position: Q4 2021 in Review

VOYA Investment Management sold out of Spero Therapeutics (SPRO) in Q4 2021, closing a stake of 10,124 shares — an estimated $186K sold.

VOYA Investment Management first reported a position in SPRO in Q3 2020 and held it in 3 quarters. The position peaked at $186K in Q3 2021. 84 funds tracked by Wall St. Rank hold SPRO as of Q4 2021.

  • VOYA Investment Management reported no remaining Spero Therapeutics position as of Q4 2021 after selling out during the quarter.
  • VOYA Investment Management sold 10,124 Spero Therapeutics shares in Q4 2021, an estimated $186K.
  • VOYA Investment Management first reported a position in Spero Therapeutics in Q3 2020 and held it in 3 quarters.
  • VOYA Investment Management's Spero Therapeutics position peaked at $186K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Spero Therapeutics as of Q4 2021.

Based on VOYA Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.